Pacagen
Cambridge, United States · Founded 2023 · $13.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2C
- Website
- pacagen.com
- Total Funding
- $13.0M
- Last Round
- $13.0M Venture RoundJan 2024
- Rounds
- 1
About
Biotech consumer brand making cat allergen neutralizing sprays and supplements using WhiskerBlock technology to eliminate Fel d 1 protein.
Summary
Pacagen is a Biotech company based in Cambridge, United States, founded in 2023. It has raised $13.0M in total across 1 round, most recently a $13.0M Venture Round round in Jan 2024. Investors include Maveron, Bantam Group and Digitalis Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company